Abstract
Aims: Angioimmunoblastic lymphoma (AITL) is a rare aggressive lymphoma that derives from T-cell follicular T-helper cells commonly affecting the elderly population. It accounts for 20% of peripheral lymphomas with a reported 5-year overall survival rate of less than 30%.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
